Unlock stock picks and a broker-level newsfeed that powers Wall Street.
KOSDAQ - Delayed Quote KRW

Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ)

Compare
6,510.00
+20.00
+(0.31%)
At close: April 4 at 3:30:30 PM GMT+9
Loading Chart for 001540.KQ
  • Previous Close 6,490.00
  • Open 6,380.00
  • Bid 6,490.00 x --
  • Ask 6,510.00 x --
  • Day's Range 6,360.00 - 6,560.00
  • 52 Week Range 6,230.00 - 8,270.00
  • Volume 17,528
  • Avg. Volume 21,672
  • Market Cap (intraday) 73.989B
  • Beta (5Y Monthly) 0.81
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield 440.00 (6.76%)
  • Ex-Dividend Date Dec 27, 2024
  • 1y Target Est --

Ahn-Gook Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products. The company's pharmaceutical products include Cinatura and Revo Tension. The company was founded in 1959 and is headquartered in Seoul, South Korea.

www.ahn-gook.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 001540.KQ

View More

Performance Overview: 001540.KQ

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .

YTD Return

001540.KQ
0.31%
KOSPI Composite Index (^KS11)
2.75%

1-Year Return

001540.KQ
15.64%
KOSPI Composite Index (^KS11)
10.09%

3-Year Return

001540.KQ
37.52%
KOSPI Composite Index (^KS11)
10.61%

5-Year Return

001540.KQ
18.99%
KOSPI Composite Index (^KS11)
42.89%

Compare To: 001540.KQ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 001540.KQ

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    73.99B

  • Enterprise Value

    121.97B

  • Trailing P/E

    4.39

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.27

  • Price/Book (mrq)

    0.45

  • Enterprise Value/Revenue

    0.45

  • Enterprise Value/EBITDA

    3.94

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.21%

  • Return on Assets (ttm)

    1.54%

  • Return on Equity (ttm)

    10.33%

  • Revenue (ttm)

    271.12B

  • Net Income Avi to Common (ttm)

    16.85B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    29.74B

  • Total Debt/Equity (mrq)

    47.18%

  • Levered Free Cash Flow (ttm)

    -82.47B

Research Analysis: 001540.KQ

View More

Company Insights: 001540.KQ

Research Reports: 001540.KQ

View More

People Also Watch